Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.
about
SEER cancer registry biospecimen research: yesterday and tomorrowComparison of cervical cancer screening results among 256,648 women in multiple clinical practices.US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccinesValidation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples.Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today.Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.Using Community Engagement to Develop a Web-Based Intervention for Latinos about the HPV Vaccine.Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers.Cervical cancer: what is the optimal age for routine testing?HPV primary screening: unanswered questions.
P2860
Q26998744-179CE42C-D15C-406D-8067-B4BCC60C90A4Q30487807-6CA51F01-C251-4D62-A15F-3B89DFB54C65Q36817074-2625ACC5-643E-44F8-BE10-3C7CD796681AQ37360505-702AE5A7-1303-48D9-8F37-77A70579A2F4Q38250275-17D2E51C-22E4-4D83-B495-E8609EAB20C2Q38373388-2C53253D-52C3-4073-8979-1258FD3EA116Q38740197-14D9BDD1-37A3-4323-8F74-4FDC1F0CC78AQ38808706-2C5852BE-2D2E-46DD-B7AA-5EB7602C67FDQ40101106-18A5792A-1D40-4EA0-8225-BE174EF0E4C5Q40301303-1A0A2176-01EC-432C-A6E0-D3319F9E44C0Q40961076-F1CFA02E-1B73-4323-AE08-076E03810178Q47572365-70D02286-881F-4C96-8276-EA0A5CE3851EQ48535452-35D8A0AB-1BF9-4AFD-9889-5338FDE27E9AQ50935034-E664A1A0-D8DF-4EA7-84CB-BCBB7A499278
P2860
Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prevalence of human papillomav ...... s before vaccine introduction.
@ast
Prevalence of human papillomav ...... s before vaccine introduction.
@en
Prevalence of human papillomav ...... s before vaccine introduction.
@nl
type
label
Prevalence of human papillomav ...... s before vaccine introduction.
@ast
Prevalence of human papillomav ...... s before vaccine introduction.
@en
Prevalence of human papillomav ...... s before vaccine introduction.
@nl
prefLabel
Prevalence of human papillomav ...... s before vaccine introduction.
@ast
Prevalence of human papillomav ...... s before vaccine introduction.
@en
Prevalence of human papillomav ...... s before vaccine introduction.
@nl
P2093
P2860
P1476
Prevalence of human papillomav ...... s before vaccine introduction.
@en
P2093
Amy Christian
Brenda Y Hernandez
Charles F Lynch
Christopher Lyu
Claudia Hopenhayn
Edward J Wilkinson
Glenn Copeland
Marc T Goodman
Maria Sibug Saber
Martin Steinau
P2860
P304
P356
10.1097/LGT.0B013E3182A577C7
P577
2014-04-01T00:00:00Z